OSAIC HOLDINGS, INC. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$27,000
+8.0%
8,7940.0%0.00%
Q2 2020$25,000
-13.8%
8,794
-17.3%
0.00%
Q1 2020$29,00010,6330.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders